Clinical Trials Browser

Phase 1 × Recruiting × Epstein-Barr Virus Infections × Clear all

NCT06908096 2026-03-06

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

Phase 1 Recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT05389423 2026-02-19

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Phase 1 Recruiting

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

NCT04664179 2025-12-12

CILESTE

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections

NCT04013802 2025-08-08

TETRAVI

Phase 1 Recruiting

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Phase 1 Recruiting

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

NCT05183490 2024-12-30

R-MVST Cells for Treatment of Viral Infections

Phase 1 Recruiting

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT06119256 2023-11-07

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Phase 1 Recruiting

Epstein-Barr Virus Infections